Evidence map›Paper›PMID 24586253›Full record

ArticlePloS one2014

The role of IKKβ in Venezuelan equine encephalitis virus infection.

Moushimi Amaya, Kelsey Voss, Gavin Sampey, Svetlana Senina, Cynthia de la Fuente, Claudius Mueller, Valerie Calvert, Kylene Kehn-Hall, Calvin Carpenter, Fatah Kashanchi and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Genetic control of alphavirus pathogenesis.Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Moushimi AmayaNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
Kelsey VossNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
Gavin SampeyNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
Svetlana SeninaNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
Cynthia de la FuenteNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
Claudius MuellerCenter for Applied Proteomics and Personalized Medicine, George Mason University, Manassas, Virginia, United States of America.
Valerie CalvertCenter for Applied Proteomics and Personalized Medicine, George Mason University, Manassas, Virginia, United States of America.
Kylene Kehn-HallNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
Calvin CarpenterNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
Fatah KashanchiNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
Charles BaileyNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
Soren MogelsvangSerpin Pharma LLC, Manassas, Virginia, United States of America.
Emanuel PetricoinCenter for Applied Proteomics and Personalized Medicine, George Mason University, Manassas, Virginia, United States of America.
Aarthi NarayananNational Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, United States of America.
George Mason University · USSerpin Pharma (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Venezuelan equine encephalitis virus (VEEV) belongs to the genus Alphavirus, family Togaviridae. VEEV infection is characterized by extensive inflammation and studies from other laboratories implicated an involvement of the NF-κB cascade in the in vivo pathology. Initial studies indicated that at early time points of VEEV infection, the NF-κB complex was activated in cells infected with the TC-83 strain of VEEV. One upstream kinase that contributes to the phosphorylation of p65 is the IKKβ component of the IKK complex. Our previous studies with Rift valley fever virus, which exhibited early activation of the NF-κB cascade in infected cells, had indicated that the IKKβ component underwent macromolecular reorganization to form a novel low molecular weight form unique to infected cells. This prompted us to investigate if the IKK complex undergoes a comparable macromolecular reorganization in VEEV infection. Size-fractionated VEEV infected cell extracts indicated a macromolecular reorganization of IKKβ in VEEV infected cells that resulted in formation of lower molecular weight complexes. Well-documented inhibitors of IKKβ function, BAY-11-7082, BAY-11-7085 and IKK2 compound IV, were employed to determine whether IKKβ function was required for the production of infectious progeny virus. A decrease in infectious viral particles and viral RNA copies was observed with inhibitor treatment in the attenuated and virulent strains of VEEV infection. In order to further validate the requirement of IKKβ for VEEV replication, we over-expressed IKKβ in cells and observed an increase in viral titers. In contrast, studies carried out using IKKβ(-/-) cells demonstrated a decrease in VEEV replication. In vivo studies demonstrated that inhibitor treatment of TC-83 infected mice increased their survival. Finally, proteomics studies have revealed that IKKβ may interact with the viral protein nsP3. In conclusion, our studies have revealed that the host IKKβ protein may be critically involved in VEEV replication.

Indexed as

AnimalsCell LineDown-RegulationEncephalitis Virus, Venezuelan EquineEncephalomyelitis, Venezuelan EquineGuinea PigsHost-Pathogen InteractionsHumansI-kappa B KinaseMiceNeuronsNF-kappa BNitrilesSignal TransductionSulfonesViral Load3-(4-methylphenylsulfonyl)-2-propenenitrileI-kappa B KinaseNF-kappa BNitrilesSulfonesViral Proteins

Identifiers

PMID24586253
PMCPMC3929299
OpenAlexW2027298878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.